(Q53505313)

15 May 2018

http://europepmc.org/abstract/MED/25975367

title

(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate? (English)

1 reference

15 May 2018

http://europepmc.org/abstract/MED/25975367

author

Clemens Decristoforo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Francesco Ceci

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Stefano Fanti

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Christian Uprimny

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Bernhard Nilica

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Llanos Geraldo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Dorota Kendler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Alexander Kroiss

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Jasmin Bektic

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Wolfgang Horninger

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Peter Lukas

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Paolo Castellucci

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Irene J Virgolini

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

15 May 2015

1 reference

15 May 2018

http://europepmc.org/abstract/MED/25975367

number of pages

11

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

1284-1294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-015-3078-6

11 June 2020

exact match

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

[18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

Alpha emitter radium-223 and survival in metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

Radiation dosimetry and first therapy results with a (124)I/ (131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

[¹⁷⁷Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

(68)Ga-PSMA ligand PET versus (18)F-NaF PET: evaluation of response to (223)Ra therapy in a prostate cancer patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

11C-choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

11C-choline PET/CT scan in patients with prostate cancer treated with intermittent ADT: a sequential PET/CT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3078-6

NCCN clinical practice guidelines in oncology: prostate cancer

21 January 2018

1 reference

12 December 2020

A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy

1 reference

12 December 2020

Prostate-specific membrane antigen expression in normal and malignant human tissues

1 reference

12 December 2020

11C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients

1 reference

12 December 2020

Simplified NaCl based (68)Ga concentration and labeling procedure for rapid synthesis of (68)Ga radiopharmaceuticals in high radiochemical purity

1 reference

12 December 2020

Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer

1 reference

12 December 2020

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects

1 reference

12 December 2020

10.1007/S00259-015-3078-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25975367%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference